{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-006536","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2023-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.979668+00:00","generated_at":"2026-06-20T09:32:11.575648+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Avenue Therapeutics dismisses BDO, engages KPMG as new auditor","bullets":["BDO dismissed as independent auditor effective Jan 21, 2023; prior reports had going concern explanatory paragraph.","No disagreements or reportable events during fiscal years 2021 and 2020 and subsequent interim periods.","KPMG engaged as new independent auditor for fiscal year ending Dec 31, 2022, effective Jan 23, 2023.","No prior consultations with KPMG on accounting principles, disagreements, or reportable events."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-006536","json":"https://secwatch.observer/filing/0001104659-23-006536.json","markdown":"https://secwatch.observer/filing/0001104659-23-006536.md","text":"https://secwatch.observer/filing/0001104659-23-006536.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000110465923006536/0001104659-23-006536-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000110465923006536/tm234276d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T09:32:11.575648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0ec49b5b3d5dc9d6a73ecab26635a671f75da7f9","claim":"AVENUE THERAPEUTICS, INC. dismissed BDO USA, LLP as its auditor.","evidence_excerpt":"On January 21, 2023, the Audit Committee (the “Audit Committee”) of the Board of Directors of Avenue Therapeutics, Inc. (the “Company”) dismissed BDO USA, LLP (“BDO”) as the Company’s independent registered public accounting firm, effective immediately.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465923006536/0001104659-23-006536-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"BDO USA, LLP"},{"label":"Successor","value":"KPMG LLP"}],"fact_type":"auditor_change"},{"claim_id":"6f447caf839b721e33249f2e8102ed6d6b0935a9","claim":"AVENUE THERAPEUTICS, INC. engaged KPMG LLP as its auditor.","evidence_excerpt":"Effective as of January 23, 2023, the Audit Committee engaged KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2022.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465923006536/0001104659-23-006536-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"KPMG LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}